Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CF

Earnings Preview: What to Expect From CF Industries’ Report

CF Industries is scheduled to report its fiscal fourth-quarter results next month, and analysts expect a double-digit increase in earnings.

Barchart

Anna Tims’ dishonours list: the not-so good, the bad and the ugly customer service awards 2025

It is time to roll out the red carpet in recognition of those that worked hard to keep customers at arm’s length

The Guardian - UK

Is CF Industries Stock Underperforming the Nasdaq?

CF has trailed the Nasdaq’s stronger performance, prompting analysts to adopt a more restrained stance on the stock’s longer-term prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Do Wall Street Analysts Like CF Industries Stock?

Despite CF Industries lagging the broader market over the past year, analysts remain reasonably upbeat regarding its future outlook.

Barchart

CF Industries' Quarterly Earnings Preview: What You Need to Know

CF Industries is all set to release its fiscal third-quarter earnings next month, and analysts project a double-digit profit rise.

Barchart

Is CF Industries Stock Underperforming the S&P 500?

CF Industries has underperformed the S&P 500 over the past year, and analysts are cautious about the stock’s prospects.

Barchart

CF Industries Stock Outlook: Is Wall Street Bullish or Bearish?

Due to CF Industries' underperformance relative to the SPX over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

This CF Industries Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

CF Industries’ Q2 2025 Earnings: What to Expect

CF Industries is scheduled to announce its second-quarter earnings next month, and analysts anticipate a single-digit decline in profit.

Barchart

How Is CF Industries’ Stock Performance Compared to Other Basic Materials Stocks?

While CF Industries has considerably outpaced its industry peers recently, analysts remain cautious about the stock’s prospects.

Barchart

Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup

The Iranian conflicts are going to bring a new bottleneck issue in the world of fertilizer stocks, which could bring about higher stock prices.

MarketBeat

These 3 Stocks Could Be Back in Play Before You Know It

There are three major upside opportunities shaping up in a sector that hasn't gotten the attention it deserves in the market today.

MarketBeat

Are Wall Street Analysts Predicting CF Industries Stock Will Climb or Sink?

Despite CF Industries' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

Barchart

CF Industries Earnings Preview: What to Expect

CF Industries is all set to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit rise.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

CF Industries Stock: Is CF Underperforming the Material Sector?

CF Industries has lagged behind the broader materials sector in recent years, with analysts maintaining a cautious outlook on its prospects.

Barchart

Is Wall Street Bullish or Bearish on CF Industries Stock?

As CF Industries underperformed the S&P 500 Index over the past 52 weeks, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

What You Need to Know Ahead of CF Industries' Earnings Release

CF Industries will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

MarketBeat

Vertex's Pain Drug: Big Pharma's Next Major Success?

Vertex Pharmaceuticals' innovative pain drug holds significant potential, positioning the company for substantial growth in the expanding market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is CF Industries Holdings Stock Underperforming the Dow?

CF Industries has continued to underperform the Dow over the past years, yet analysts remain optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on CF Industries Stock?

CF Industries has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

What to Expect From CF Industries' Next Quarterly Earnings Report

CF Industries is scheduled to report its third-quarter results next week, and analysts expect a double-digit earnings growth.

Barchart

Is CF Industries Stock Underperforming the Nasdaq?

CF Industries has lagged behind the Nasdaq Composite over the past year, yet analysts remain cautiously optimistic about the stock's future.

Barchart

What Are Wall Street Analysts' Target Price for CF Industries Stock?

CF Industries has significantly underperformed the broader market this year, but Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart

What to Expect From CF Industries’ Q2 2024 Earnings Report

CF Industries is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit dip.

Barchart

3 Agricultural Chemical Stocks to Avoid, According to Piper Sandler

With corn prices getting crushed, here are three agricultural chemical stocks to avoid, according to Piper Sandler.

1 2 3

Organisations

Vertex Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Pain Management

54 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.